Literature DB >> 12170264

Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor.

Takumi Takizawa1, Masahiko Kato, Hirokazu Kimura, Masato Suzuki, Atsushi Tachibana, Hideru Obinata, Takashi Izumi, Kenichi Tokuyama, Akihiro Morikawa.   

Abstract

BACKGROUND: Platelet-activating factor (PAF) is a potent stimulator of human eosinophils involved in the pathogenesis of allergic diseases. However, intracellular signaling mechanisms in eosinophils involving the PAF receptor are incompletely understood.
OBJECTIVE: We sought to determine the roles of protein kinase C (PKC) and cyclic AMP-dependent protein kinase (protein kinase A [PKA]) in signaling pathways of human eosinophils stimulated with PAF.
METHODS: After pretreatment with a PKC inhibitor, bisindolylmaleimide I, or a PKA inhibitor, H89, we investigated PAF-evoked functions, such as CD11b expression, cellular adhesion, superoxide anion generation, and degranulation in human eosinophils.
RESULTS: Preincubation of eosinophils with bisindolylmaleimide I resulted in enhancement of upregulated CD11b expression and adhesion induced by PAF. H89 pretreatment also enhanced PAF-induced cellular adhesion. Superoxide anion generation and degranulation were suppressed by means of inhibition of either PKC or PKA.
CONCLUSION: PKC and PKA negatively regulate PAF-induced CD11b upregulation and cellular adhesion but promote eosinophil effector functions, such as superoxide anion generation and degranulation. PKC and PKA modulate PAF-evoked intracellular signaling of the eosinophil function in distinct ways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170264     DOI: 10.1067/mai.2002.126303

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

2.  An atypical protein kinase C, PKC zeta, regulates human eosinophil effector functions.

Authors:  Masahiko Kato; Takafumi Yamaguchi; Atsushi Tachibana; Masato Suzuki; Takashi Izumi; Kenichi Maruyama; Yasuhide Hayashi; Hirokazu Kimura
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated L-plastin.

Authors:  Konrad Pazdrak; Travis W Young; Christof Straub; Susan Stafford; Alexander Kurosky
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

4.  The tripeptide feG regulates the production of intracellular reactive oxygen species by neutrophils.

Authors:  Ronald D Mathison; Joseph S Davison
Journal:  J Inflamm (Lond)       Date:  2006-06-15       Impact factor: 4.981

5.  Exposure to bisphenol A enhanced lung eosinophilia in adult male mice.

Authors:  Miao He; Takamichi Ichinose; Seiichi Yoshida; Hirohisa Takano; Masataka Nishikawa; Takayuki Shibamoto; Guifan Sun
Journal:  Allergy Asthma Clin Immunol       Date:  2016-04-14       Impact factor: 3.406

6.  Eosinophil recruitment and activation: the role of lipid mediators.

Authors:  Tatiana Luna-Gomes; Patrícia T Bozza; Christianne Bandeira-Melo
Journal:  Front Pharmacol       Date:  2013-03-22       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.